proactiveinvestors.com
Medicus Pharma marks Nasdaq milestone as it advances Phase 2 clinical programs
Medicus Pharma (NASDAQ:MDCX) has marked the one-year anniversary of its Nasdaq listing on Thursday by ringing the Opening Bell at the Nasdaq MarketSite in New York's Times Square. CEO Dr Raza Bokhari said the company was honored with the opportunity, describing the milestone as a reflection of Medicus' progress since going public and its continued focus on disciplined execution across a streamlined and strategically selected clinical portfolio.
